Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
performed on 40 randomized clinical trials including T2DM patients showed that GLP1-RAs reduce oxidative stress and the levels of inflammatory markers including CRP [50]
Whether you are dealing with rheumatoid arthritis (RA), psoriatic arthritis (PsA), lupus (SLE), Sjgrens disease (SD), or even osteoarthritis (OA), chronic inflammation keeps the immune system in a constant attack mode, leading to: Pain Swelling Stiffness Mobility problems Tissue and cartilage damage This chronic, ongoing inflammation not only makes joints hurt more, but it will worsen blood sugar control, fatigue, brain fog, and increase the risk of heart disease
The result is a profound Wegovy appetite suppression that silences the food noise and restores a sense of control
Commonly reported issues include: Gastrointestinal Distress: Nausea, vomiting, and diarrhea are common, particularly when starting the medication
Kosiborod MN, Deanfield J, Pratley R, et al
